-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JPnCz2bocZEWKjAwsRH2nqjsLVSqLQ/Ek+urh/6oFp/AeB90kSlP5jfgkJbqCmbY N7ojFMrMHTAimEqJD7uX7Q== 0000930413-04-000459.txt : 20040217 0000930413-04-000459.hdr.sgml : 20040216 20040217165547 ACCESSION NUMBER: 0000930413-04-000459 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040217 GROUP MEMBERS: J. P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), II, L.P. GROUP MEMBERS: J. P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), L.P. GROUP MEMBERS: J. P. MORGAN PARTNERS GLOBAL INVESTORS A, L.P. GROUP MEMBERS: J. P. MORGAN PARTNERS GLOBAL INVESTORS, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NUCO2 INC /FL CENTRAL INDEX KEY: 0000947577 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-CHEMICALS & ALLIED PRODUCTS [5160] IRS NUMBER: 650180800 STATE OF INCORPORATION: FL FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-46469 FILM NUMBER: 04609710 BUSINESS ADDRESS: STREET 1: 2800 S E MARKET PLACE CITY: STUART STATE: FL ZIP: 34997 BUSINESS PHONE: 5612211754 MAIL ADDRESS: STREET 1: 2820 SE MARKET PLACE CITY: STUART STATE: FL ZIP: 34997 FORMER COMPANY: FORMER CONFORMED NAME: FOWLER CARBONICS INC DATE OF NAME CHANGE: 19951108 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JP MORGAN PARTNERS BHCA LP CENTRAL INDEX KEY: 0001106607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: J.P. MORGAN PARTNERS STREET 2: 1221 AVENUE OF THE AMERICAS 40TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2128993400 MAIL ADDRESS: STREET 1: J.P. MORGAN PARTNERS STREET 2: 1221 AVENUE OF THE AMERICAS 40TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 FORMER COMPANY: FORMER CONFORMED NAME: CHASE EQUITY ASSOCIATES LLC DATE OF NAME CHANGE: 20000214 SC 13G/A 1 c30793_sc13g-a.txt ------------------------------ OMB APPROVAL ------------------------------ OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response....... 11 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* NuCo2, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 629428103 -------------------------------------------- (CUSIP Number) August 25, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). J.P. Morgan Partners (BHCA), L.P. (as successor by merger of Chase Capital Investments, L.P. with and into J.P. Morgan Partners (BHCA), L.P.) 13-337-1826 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 1,532,190 (includes Warrants to purchase 857,551 shares, Options to purchase 20,000 shares, 8% Convertible Preferred Stock immediately convertible into 654,639 5. Sole Voting Power shares) Number of Shares --------------------------------------------------------- Beneficially Owned 6. Shared Voting Power by Each Reporting --------------------------------------------------------- Person With: 1,532,190 (includes Warrants to purchase 857,551 shares, Options to purchase 20,000 shares, 8% Convertible Preferred Stock immediately 7. Sole convertible into 654,639 Dispositive Power shares) --------------------------------------------------------- 8. Shared Dispositive Power - -------------------------------------------------------------------------------- 1,532,190 (includes Warrants to purchase 857,551 shares, Options to purchase 20,000 shares, 8% Convertible Preferred Stock immediately 9. Aggregate Amount Beneficially Owned convertible into 654,639 by Each Reporting Person shares) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 12.6% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) - -------------------------------------------------------------------------------- PN ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. - -------------------------------------------------------------------------------- 2 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). J.P. Morgan Partners Global Investors, L.P. 13-4197054 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power Warrant to purchase 33,795 shares ---------------------------------------------------------- Number of Shares 6. Shared Beneficially Voting Power Owned by Each ---------------------------------------------------------- Reporting Person 7. Sole With: Dispositive Power Warrant to purchase 33,795 shares ---------------------------------------------------------- 8. Shared Dispositive Power - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person Warrant to purchase 33,795 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) .4% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) - -------------------------------------------------------------------------------- PN ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. - -------------------------------------------------------------------------------- 3 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). J.P. Morgan Partners Global Investors A, L.P. 26-0032493 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power Warrant to purchase 5,193 shares ----------------------------------------------------------- Number of Shares 6. Shared Beneficially Voting Power Owned by Each ----------------------------------------------------------- Reporting Person 7. Sole With: Dispositive Power Warrant to purchase 5,193 shares ----------------------------------------------------------- 8. Shared Dispositive Power - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person Warrant to purchase 5,193 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) .2% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) - -------------------------------------------------------------------------------- PN ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. - -------------------------------------------------------------------------------- 4 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 - ------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). J.P. Morgan Partners Global Investors (Cayman), L.P. 13-4197057 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Cayman Islands - -------------------------------------------------------------------------------- 5. Sole Voting Power Warrant to purchase 16,967 shares ----------------------------------------------------------- Number of Shares 6. Shared Beneficially Voting Power Owned by Each ----------------------------------------------------------- Reporting Person 7. Sole With: Dispositive Power Warrant to purchase 16,967 shares ----------------------------------------------------------- 8. Shared Dispositive Power - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person Warrant to purchase 16,967 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) .3% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) - -------------------------------------------------------------------------------- PN ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. - -------------------------------------------------------------------------------- 5 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 - ------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). J.P. Morgan Partners Global Investors (Cayman) II, L.P. 26-0005546 - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Cayman Islands - -------------------------------------------------------------------------------- 5. Sole Voting Power Warrant to purchase 1,897 shares ----------------------------------------------------------- Number of Shares 6. Shared Beneficially Voting Power Owned by Each ----------------------------------------------------------- Reporting Person 7. Sole With: Dispositive Power Warrant to purchase 1,897 shares ----------------------------------------------------------- 8. Shared Dispositive Power - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person Warrant to purchase 1,897 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) .1% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) - -------------------------------------------------------------------------------- PN ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. ................................................................................. - -------------------------------------------------------------------------------- 6 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 PRELIMINARY NOTE: The information contained in this Schedule 13G has been amended to reflect the granting of Warrants to purchase, in the aggregate, 250,000 shares of the Issuer's Common Stock and a change in the Controlling Persons of the Reporting Person. ITEM 1. (A) NAME OF ISSUER: NuCo2, Inc. (B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 2800 SE Market Place Stuart, Florida 34997 ITEM 2. (A) NAME OF PERSON FILING: J.P. Morgan Partners (BHCA), L.P. ("JPMP BHCA") J.P. Morgan Partners Global Investors, L.P. ("JPMP Global") J.P. Morgan Partners Global Investors A, L.P. ("JPMP Global A") J.P. Morgan Partners Global Investors (Cayman), L.P. ("JPMP Cayman") J.P. Morgan Partners Global Investors (Cayman) II, L.P. ("JPMP Cayman II") Supplemental information relating to the ownership and control of the person filing this statement is included in Exhibit 2(a) attached hereto. (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: c/o J.P. Morgan Partners, LLC 1221 Avenue of the Americas New York, New York 10020 (C) CITIZENSHIP: Delaware (D) TITLE OF CLASS OF SECURITIES (OF ISSUER): Common Stock (E) CUSIP NUMBER: 629428103 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.SS. 240. 13d-1(b) OR 240. 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not applicable. 7 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 ITEM 4. OWNERSHIP (A) AMOUNT BENEFICIALLY OWNED: JPMP (BHCA): 1,532,190 (includes Warrants to purchase 857,551 shares, Options to purchase 20,000 shares and 8% Convertible Preferred Stock, immediately convertible into 654,639 shares). JPMP GLOBAL: Warrant to purchase 33,795 shares JPMP GLOBAL A: Warrant to purchase 5,193 shares JPMP CAYMAN: Warrant to purchase 16,967 shares JPMP CAYMAN II: Warrant to purchase 1,897 shares (B) PERCENT OF CLASS: JPMP (BHCA): 12.6% (as of December 31, 2003) JPMP GLOBAL: .4% (as of December 31, 2003) JPMP GLOBAL A: .3% (as of December 31, 2003) JPMP CAYMAN: .1% (as of December 31, 2003) JPMP CAYMAN II: .2% (as of December 31, 2003) (C) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) JPMP (BHCA): 1,237,637 (Warrants to purchase 651,042 shares, Options to purchase 20,000 shares and 8% Convertible Preferred Stock immediately convertible into 654,639 shares) JPMP GLOBAL: Warrant to purchase 33,795 shares JPMP GLOBAL A: Warrant to purchase 5,193 shares JPMP CAYMAN: Warrant to purchase 16,967 shares JPMP CAYMAN II: Warrant to purchase 1,897 shares (ii) Not applicable. (iii) JPMP (BCHA): 1,237,637 (Warrants to purchase 651,042 shares, Options to purchase 20,000 shares and 8% Convertible Preferred Stock immediately convertible into 654,639 shares) JPMP GLOBAL: Warrant to purchase 33,795 shares JPMP GLOBAL A: Warrant to purchase 5,193 shares JPMP CAYMAN: Warrant to purchase 16,967 shares JPMP CAYMAN II: Warrant to purchase 1,897 shares (iv) Not applicable. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable. 8 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable. ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 9 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 11, 2004 J.P. MORGAN PARTNERS (BHCA), L.P. By: JPMP Master Fund Manager, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President 10 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 J.P. MORGAN PARTNERS GLOBAL INVESTORS A, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN) II, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President 11 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is accurate. Dated this 11th day of February, 2004. J.P. MORGAN PARTNERS (BHCA), L.P. By: JPMP Capital Corp., Its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS A, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President 12 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN) II, L.P. By: JPMP Global Investors, L.P., its General Partner By: JPMP Capital Corp., its General Partner By: /s/ Jeffrey C. Walker --------------------------------------- Name: Jeffrey C. Walker Title: President 13 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 EXHIBIT 2(A) This statement is being filed by J.P. Morgan Partners (BHCA), L.P., (as successor by merger of Chase Capital Investments, L.P. with and into J.P. Morgan Partners (BHCA), L.P.), a Delaware limited partnership (hereinafter referred to as "JPMP (BHCA)"), whose principal business office is located 1221 Avenue of the Americas, New York, New York 10020. JPMP (BHCA) is engaged in the venture capital and leveraged buyout business. The general partner of JPMP (BHCA) is JPMP Master Fund Manager, L.P. (formerly known as Chase Capital Partners, a New York general partnership), a Delaware limited partnership (hereinafter referred to as "JPMP Master Fund"), whose principal business office is located at the same address as JPMP (BHCA), and is also engaged directly and indirectly (through affiliates) in the venture capital and leveraged buyout business. This statement is also being filed by J.P. Morgan Partners Global Investors, L.P., a Delaware limited partnership ("JPMP Global"), whose principal place of business is located at the same address as JPMP (BHCA); J.P. Morgan Partners Global Investors A, L.P., a Delaware limited partnership ("JPMP Global A"), whose principal place of business is located at the same address as JPMP (BHCA); J.P. Morgan Partners Global Investors (Cayman), L.P., a Cayman Islands limited partnership ("JPMP Cayman"), whose principal place of business is located at the same address as JPMP (BHCA); and J.P. Morgan Partners Global Investors (Cayman) II, L.P., a Cayman Islands limited partnership ("JPMP Cayman II" and collectively with JPMP Global, JPMP Global A and JPMP Cayman, the "Global Fund Entities"), whose principal place of business is located at the same address as JPMP (BHCA). Each of the Global Fund Entities is also engaged in the venture capital and leveraged buyout business. The general partner of each of the Global Fund Entities is JPMP Global Investors, L.P., a Delaware limited partnership ("JPMP Investors"), whose principal place of business is located at the same address as JPMP (BHCA). JPMP Investors is engaged indirectly in the venture capital and leveraged buyout business as general partner of each of the Global Fund Entities. The general partner of each of JPMP Master Fund and JPMP Investors, L.P. is JPMP Capital Corp. (formerly known as Chase Capital Corporation), a New York corporation (hereinafter referred to as "JPMP Capital Corp."), whose principal business office is located at the same address as JPMP (BHCA), and is also engaged directly and indirectly (through affiliates) in the venture capital and leveraged buyout business. Set forth in Schedule A hereto and incorporated herein by reference are the names, business addresses, principal occupations and employments of each executive officer and director of JPMP Capital Corp. JPMP Capital Corp. is a wholly owned subsidiary of J.P. Morgan Chase & Co. (formerly known as The Chase Manhattan Corporation), a Delaware corporation (hereinafter referred to as "JP Morgan Chase") which is engaged (primarily through subsidiaries) in the commercial banking business with its principal office located at 270 Park Avenue, New York, New York 10017. Set forth in Schedule B hereto and incorporated herein by reference are the names, business addresses, principal occupations and employments of each executive officer and director of JP Morgan Chase. 14 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 SCHEDULE A JPMP CAPITAL CORP. EXECUTIVE OFFICERS(1) President Jeffrey C. Walker* Chief Investment Officer Arnold L. Chavkin* Managing Director Dr. Dana Beth Ardi* Managing Director Christopher C. Behrens* Managing Director Julie Casella-Esposito* Managing Director Rodney A. Ferguson* Managing Director Cornell P. French* Managing Director Michael R. Hannon* Managing Director Alfredo Irigoin* Managing Director Andrew Kahn* Managing Director Jonathan R. Lynch* Managing Director Stephen P. Murray* Managing Director Timothy Purcell* Managing Director Faith Rosenfeld* Managing Director Shahan D. Soghikian* Managing Director Timothy J. Walsh* Managing Director Richard D. Waters, Jr.* Managing Director Damion E. Wicker, M.D.* DIRECTORS(1) William B. Harrison** Jeffrey C. Walker* - -------- (1) Each of whom is a United States citizen except for Mr. Irigoin. * Principal occupation is employee and/or officer of J.P. Morgan Partners, LLC. Business address is c/o J.P. Morgan Partners, LLC, 1221 Avenue of the Americas, New York, New York 10020. ** Principal occupation is employee or officer of J.P. Morgan Chase & Co. Business address is c/o J.P. Morgan Chase & Co., 270 Park Avenue, New York, New York 10017. 15 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 SCHEDULE B J.P. MORGAN CHASE & CO. EXECUTIVE OFFICERS(1) Chairman of the Board and Chief Executive Officer William B. Harrison Jr.* Vice Chairman David A. Coulter* Vice Chairman Thomas B. Ketchum* Vice Chairman Donald H. Layton* Vice Chairman Jeffrey C. Walker** Vice Chairman; Head of Finance, Risk Management and Administration Marc J. Shapiro* Executive Officer Donald H. McCree III* Executive Vice President; Chief Financial Officer Dina Dublon* Executive Vice President; Head of Market Risk Management Lesley Daniels Webster* General Counsel William H. McDavid* Director of Human Resources John J. Farrell* Director of Corporate Marketing and Communications Frederick W. Hill* Controller Joseph L. Scalfani* - -------- (1) Each of whom is a United States citizen. * Principal occupation is employee or officer of J.P. Morgan Chase & Co. Business address is c/o J.P. Morgan Chase & Co., 270 Park Avenue, New York, New York 10017. ** Principal occupation is employee and/or officer of J.P. Morgan Partners, LLC. Business address is c/o J.P. Morgan Partners, LLC, 1221 Avenue of the Americas, New York New York 10020. 16 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 DIRECTORS(1) PRINCIPAL OCCUPATION OR EMPLOYMENT; NAME BUSINESS OR RESIDENCE ADDRESS - -------------------------------------------------------------------------------- Hans W. Becherer Retired Chairman of the Board and Chief Executive Officer Deere & Company One John Deere Place Moline, IL 61265 - -------------------------------------------------------------------------------- Riley P. Bechtel Chairman and Chief Executive Officer Bechtel Group, Inc. P.O. Box 193965 San Francisco, CA 94119-3965 - -------------------------------------------------------------------------------- Frank A. Bennack, Jr. President and Chief Executive Officer The Hearst Corporation 959 Eighth Avenue New York, New York 10019 - -------------------------------------------------------------------------------- John H. Biggs Former Chairman and Chief Executive Officer TIAA-CREF 730 Third Avenue 25th Floor New York, NY 10017 - -------------------------------------------------------------------------------- Lawrence A. Bossidy Chairman of the Board Honeywell International P.O. Box 3000 Morristown, NJ 07962-2245 - -------------------------------------------------------------------------------- M. Anthony Burns Chairman of the Board Ryder System, Inc. 3600 N.W. 82nd Avenue Miami, Florida 33166 - -------------------------------------------------------------------------------- Ellen V. Futter President and Trustee American Museum of Natural History Central Park West at 79th Street New York, NY 10024 - -------------------------------------------------------------------------------- William H. Gray, III President and Chief Executive Officer The College Fund/UNCF 9860 Willow Oaks Corporate Drive P.O. Box 10444 Fairfax, Virginia 22031 - -------------------------------------------------------------------------------- William B. Harrison, Jr. Chairman of the Board and Chief Executive Officer J.P. Morgan Chase & Co. 270 Park Avenue, 8th Floor New York, New York 10017-2070 - -------------------------------------------------------------------------------- - -------- (1) Each of whom is a United States citizen. * Principal occupation is employee or officer of J.P. Morgan Chase & Co. Business address is c/o J.P. Morgan Chase & Co., 270 Park Avenue, New York, New York 10017. ** Principal occupation is employee and/or officer of J.P. Morgan Partners, LLC. Business address is c/o J.P. Morgan Partners, LLC, 1221 Avenue of the Americas, New York New York 10020. 17 SCHEDULE 13G ISSUER: NuCo2 CUSIP NO.: 629428103 PRINCIPAL OCCUPATION OR EMPLOYMENT; NAME BUSINESS OR RESIDENCE ADDRESS - -------------------------------------------------------------------------------- Helene L. Kaplan Of Counsel Skadden, Arps, Slate, Meagher & Flom LLP Four Times Square New York, New York 10036 - -------------------------------------------------------------------------------- Lee R. Raymond Chairman of the Board and Chief Executive Officer Exxon Mobil Corporation 5959 Las Colinas Boulevard Irving, TX 75039-2298 - -------------------------------------------------------------------------------- John R. Stafford Chairman of the Board American Home Products Corporation 5 Giralda Farms Madison, New Jersey 07940 - -------------------------------------------------------------------------------- 18 -----END PRIVACY-ENHANCED MESSAGE-----